Chinaworld

Mother of FemTech, former CEO and chairwoman of Clue. Senior advisor on women's health at SPRIND. Pioneered the global transition of women's health from a neglected field to an investable, scalable industry.

Early-stage investor in women's health (Foreground Capital / formerly RH Capital). Former McKinsey San Francisco women's health investment research lead, combining clinical medicine and capital operations to support women's health innovation from research to commercialization.

Maaike is a leading voice on Femtech in Asia, a region where Femtech and women's health is underserved, underfunded, under researched and at times, a taboo topic. She launched Femtech Future Limited, an advisory firm that consults to Femtech companies and MNCs from different industries.

Founded FemTech Association Asia in October 2021 — the region's first and largest specialist advisory and industry network for women's health technology, representing 80+ companies across 10 countries.

Cofounder of the Nordic Women's Health Hub. Founder of the Nordic Hardware Women community, member of the Danish Design Council, and FemTech expert at the Danish Engineers Association. PhD from Aalborg University.

Director of Global Clinical Programs at Vira Health. Harvard Medical School graduate, trained in OB/GYN at Johns Hopkins Hospital and urogynecology at Mayo Clinic. Focuses on pelvic floor health and peripartum risk management.

Serial entrepreneur and founder of Hyivy Health, a pelvic rehabilitation device company. Founder of Femtech Canada and Femtech Across Borders, and Professor of Biotech Innovation at Toronto Metropolitan University, with over 15 years across the entrepreneurship ecosystem.

Central Markets Leader and Financial Services Tax Leader (Central China) at PwC China. CICPA and CTAA member with over two decades of tax consulting experience, specialising in cross-border investment structures and M&A transactions.

Leads strategic initiatives across Bayer's women's healthcare portfolio in China, spanning reproductive health, contraception and menopause. Bridges global pharmaceutical innovation with the evolving needs of Chinese women and clinicians.

Founder of Dayima (大姨妈), one of China's earliest and largest women's health platforms — pioneering menstrual tracking and broader women's health services for hundreds of millions of users.

Co-creator and General Partner of Amboy Street Ventures Fund I — the only venture capital platform dedicated exclusively to investing in sexual and women's health technology. Clinical sexologist and three-time UN Delegate.

Engineering student from Denmark currently working at Innovation Centre Denmark in Shanghai. Supports Danish stakeholders interested in China within life science fields including women's health.

US-certified clinical sexologist with cross-cultural expertise in women's sexual health, intimate wellness and patient education — bridging Western clinical sexology practice with the Chinese cultural context.

China Market Representative at AVPN — Asia's largest network of social investors. ESG and impact investing strategist driving cross-border collaborations on sustainability agendas.

Brings a perspective shaped by women's health innovation and ecosystem building beyond the markets that usually dominate. At a time when women's health is becoming a global movement, voices from Central Asia and neighbouring markets remain underrepresented.

Founder of The Billion Dollar Blindspot, a capital intelligence platform at the intersection of women's health and institutional finance. Brings more than 25 years of institutional capital markets experience.

Co-Founder & CEO of Heranova Lifesciences, a global women's health biotechnology company. Serial entrepreneur and venture investor with 20 years in multinational biopharma strategy and business development.

Counsellor for Healthcare & Life Sciences at the UK Department for Business and Trade, British Embassy Beijing, leading UK–China trade and investment. Previously spent six years at DBT London HQ.

Healthtech regulatory expert based in Switzerland specialising in innovation at the edge between the medical and wellness markets. Ph.D. in Chemistry from University of York.

Research Fellow (Ph.D.) and Director of Smart Healthcare Development at Renji Hospital. Brings multi-disciplinary leadership across clinical care, research and teaching management in a major comprehensive public hospital.